Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS46001058BKPyvENSG00000102755.13protein_codingFLT1YesNo2321L7RSL3
P17948
TVIS46001458BKPyvENSG00000102755.13protein_codingFLT1YesNo2321L7RSL3
P17948
TVIS10018710HBVENSG00000102755.13protein_codingFLT1YesNo2321L7RSL3
P17948
TVIS30010291HIVENSG00000102755.13protein_codingFLT1YesNo2321L7RSL3
P17948
TVIS30017984HIVENSG00000102755.13protein_codingFLT1YesNo2321L7RSL3
P17948
TVIS30034815HIVENSG00000102755.13protein_codingFLT1YesNo2321L7RSL3
P17948
TVIS30034816HIVENSG00000102755.13protein_codingFLT1YesNo2321L7RSL3
P17948
TVIS30034817HIVENSG00000102755.13protein_codingFLT1YesNo2321L7RSL3
P17948
TVIS30034818HIVENSG00000102755.13protein_codingFLT1YesNo2321L7RSL3
P17948
TVIS30034819HIVENSG00000102755.13protein_codingFLT1YesNo2321L7RSL3
P17948
TCGA Plot Options
Drug Information
GeneFLT1
DrugBank IDDB06626
Drug NameAxitinib
Target IDBE0000029
UniProt IDP17948
Regulation Typeinhibitor
PubMed IDs18541897
CitationsCohen EE, Rosen LS, Vokes EE, Kies MS, Forastiere AA, Worden FP, Kane MA, Sherman E, Kim S, Bycott P, Tortorici M, Shalinsky DR, Liau KF, Cohen RB: Axitinib is an active treatment for all histologic subtypes of advanced thyroid cancer: results from a phase II study. J Clin Oncol. 2008 Oct 10;26(29):4708-13. doi: 10.1200/JCO.2007.15.9566. Epub 2008 Jun 9.
GroupsApproved; Investigational
Direct ClassificationDiarylthioethers
SMILESCNC(=O)C1=C(SC2=CC=C3C(NN=C3C=CC3=CC=CC=N3)=C2)C=CC=C1
Pathways
PharmGKBPA164924493
ChEMBLCHEMBL1289926